| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | NACA2 |
| Uniprot No | Q9H009 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-215 aa |
| 活性数据 | MPGEATETVP ATEQELPQSQ AETGSGTASD SGESVPGIEE QDSTQTTTQK AWLVAAAEID EEPVGKAKQS RSEKRARKAM SKLGLLQVTG VTRVTIWKSK NILFVITKLD VYKSPASDAY IVFGEAKIQD LSQQAQLAAA EKFRVQGEAV GNIQENTQTP TVQEESEEEE VDETGVEVKD VKLVMSQANV SRAKAVRALK NNSNDIVNAI MELTV |
| 分子量 | 23.2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇与重组人NACA2(或相关异构体)蛋白相关的文献示例(部分信息为基于领域知识模拟，具体文献需检索验证)：
1. **文献名称**: "Expression and functional characterization of recombinant human NACα2 in E. coli"
**作者**: Li Y. et al.
**摘要**: 研究报道了在大肠杆菌中成功表达并纯化重组人NACα2蛋白，优化了表达条件并通过圆二色谱验证其二级结构完整性。功能实验表明该蛋白在体外能够抑制错误折叠蛋白聚集。
2. **文献名称**: "NACA2 interacts with ribosomes to regulate co-translational protein folding"
**作者**: Wang X. et al.
**摘要**: 通过哺乳动物细胞系表达带His标签的重组人NACA2蛋白，结合免疫共沉淀和冷冻电镜技术，证明NACA2与核糖体结合并参与新生肽链的共翻译折叠调控。
3. **文献名称**: "Structural insights into the NAC domain of human NACA2 by X-ray crystallography"
**作者**: Suzuki K. et al.
**摘要**: 利用昆虫细胞表达系统制备重组人NACA2蛋白，解析了其NAC结构域的晶体结构(分辨率2.1Å)，揭示了该结构域与mRNA结合的关键氨基酸位点。
4. **文献名称**: "Aberrant NACA2 expression promotes tumor metastasis via stabilizing c-Myc in hepatocellular carcinoma"
**作者**: Zhang R. et al.
**摘要**: 研究中在HEK293细胞中重组表达NACA2蛋白，通过蛋白互作组学发现其与c-Myc直接结合，并通过体外细胞迁移实验验证其促进肝癌转移的分子机制。
---
**备注**：以上为模拟文献，实际研究中需通过PubMed或Google Scholar检索以下关键词验证：
`"recombinant NACA2"`, `"NACα2 expression"`, `"human NACA2 protein"`, 并核对基因别名(如NACA2可能标注为NACA或NACA isoform 2)。真实文献可能侧重表达系统优化、结构解析或疾病相关功能研究。
**Background of Recombinant Human NACA2 Protein**
The human Nascent polypeptide-Associated Complex Alpha subunit 2 (NACA2), also known as NAC-α2. is a component of the NAC complex, a conserved eukaryotic heterodimer critical for protein biogenesis. The NAC complex, comprising NACA1 and NACA2 subunits, interacts with ribosomes to assist in cotranslational folding, prevent premature protein aggregation, and facilitate proper targeting of nascent polypeptide chains. NACA2 shares homology with NACA1 but exhibits distinct expression patterns and regulatory roles, particularly in stress responses and developmental processes.
Recombinant human NACA2 protein is engineered using expression systems like *E. coli* or mammalian cells to study its structure and function. It retains the ability to bind ribosomes and nascent polypeptides, making it a valuable tool for investigating protein synthesis quality control mechanisms. Studies suggest its involvement in neurodegenerative diseases, such as Alzheimer’s, where protein misfolding is a hallmark. Additionally, NACA2 has been linked to cancer progression due to its role in regulating apoptosis and cellular stress pathways.
Research on recombinant NACA2 aids in elucidating its interactions with molecular chaperones, ribosomal components, and signaling pathways, providing insights into therapeutic strategies for protein-misfolding disorders and malignancies. Its application extends to *in vitro* assays, structural studies, and drug discovery platforms targeting NAC-mediated cellular processes.
×
